Zhongguancun (000931.SZ) subsidiary Duoduo Pharmaceutical's calcium dobesilate capsule marketing authorization application accepted

Zhitong Finance APP News, Zhongguancun (000931.SZ) announced that its subsidiary Duoduo Pharmaceutical Co., Ltd. (hereinafter referred to as: Duoduo Pharmaceutical) recently received the "Notice of Acceptance" issued by the National Medical Products Administration (hereinafter referred to as: NMPA), and the marketing authorization application for Calcium Dobesilate Capsules (specification: 0.5g) has been accepted.